Literature DB >> 4333892

Antiviral activity in tissue culture systems of bis-benzimidazoles, potent inhibitors of rhinoviruses.

J B Schleicher, F Aquino, A Rueter, W R Roderick, R N Appell.   

Abstract

(S,S)-1,2-bis(5-methoxy-2-benzimidazolyl)-1,2-ethanediol showed antiviral activity in monolayer tissue culture systems against 55 strains of rhinovirus, three types of poliovirus, and strains of type A and B coxsackieviruses. Neither the compound nor any of the analogues tested showed virucidal activity. Its antiviral activity was not associated with interference with viral attachment to or penetration into the cell. At a concentration of 0.1 mg/ml, this group of compounds was generally nontoxic to WI-38, primary bovine kidney, and African green monkey kidney cells and had antiviral activity with 100% inhibition of virus-induced cytopathic effects (CPE). At antiviral levels, these compounds prevented CPE of up to 10(6) median tissue culture infective dose units of virus and completely inhibited formation of new infective virions. The compounds showed antiviral activity both prophylactically and therapeutically against rhinoviruses. Infected cultures could be cleared of CPE up to 90 hr after infection.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4333892      PMCID: PMC380287          DOI: 10.1128/am.23.1.113-116.1972

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  7 in total

1.  Differences in the selective virus inhibitory action of 2-(alpha-hydroxybenzyl)-benzimidazole and guanidine HCl.

Authors:  I TAMM; H J EGGERS
Journal:  Virology       Date:  1962-11       Impact factor: 3.616

2.  Effects of certain purines and related compounds on virus propagation.

Authors:  A C HOLLINSHEAD; P K SMITH
Journal:  J Pharmacol Exp Ther       Date:  1958-05       Impact factor: 4.030

3.  The influence of chemicals on the propagation of poliomyelitis virus in tissue culture.

Authors:  G C BROWN
Journal:  J Immunol       Date:  1952-10       Impact factor: 5.422

4.  Antiviral activity and molecular features of benzimidazoles.

Authors:  D G O'Sullivan; C Ludlow; D Pantic; A K Wallis
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1969

5.  The spectrum of rhinovirus inhibitor by 2-(alpha-hydroxybenzyl)-benzimidazole and D-(-)-2-(alpha-hydroxybenzyl)-benzimidazole HC1.

Authors:  J M Gwaltney
Journal:  Proc Soc Exp Biol Med       Date:  1968-11

6.  Inhibitory effect of 1,2-bis(2-benzimidazolyl)-1,2-ethanediol derivatives on poliovirus.

Authors:  S Akihama; M Okude; K Sato; S Iwabuchi
Journal:  Nature       Date:  1968-02-10       Impact factor: 49.962

Review 7.  Antiviral chemotherapy.

Authors:  H J Eggers; I Tamm
Journal:  Annu Rev Pharmacol       Date:  1966       Impact factor: 13.820

  7 in total
  5 in total

Review 1.  Replication of rhinoviruses.

Authors:  B E Butterworth; R R Grunert; B D Korant; K Lonberg-Holm; F H Yin
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

2.  Characteristics of the in vitro inhibition of arenavirus synthesis by bis-benzimidazoles.

Authors:  J P Stella; K D Yankaskas; J H Morgan; M P Fox; C J Pfau
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

3.  Antiviral activity of a bis-benzimidazole against experimental rhinovirus infections in chimpanzees.

Authors:  N L Shipkowitz; R R Bower; J B Schleicher; F Aquino; R N Appell; W R Roderick
Journal:  Appl Microbiol       Date:  1972-01

4.  Rhinoviruses.

Authors:  J M Gwaltney
Journal:  Yale J Biol Med       Date:  1975-03

Review 5.  Diagnosis of viral disease and the advent of antiviral drugs.

Authors:  E C Herrmann; J A Herrmann
Journal:  Pharmacol Ther       Date:  1979       Impact factor: 12.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.